Alternative splicing regulation of telomerase

A new paradigm?

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Alternative splicing affects approximately 95% of eukaryotic genes, greatly expanding the coding capacity of complex genomes. Although our understanding of alternative splicing has increased rapidly, current knowledge of splicing regulation has largely been derived from studies of highly expressed mRNAs. Telomerase is a key example of a protein that is alternatively spliced, but it is expressed at very low levels and although it is known that misregulation of telomerase splicing is a hallmark of nearly all cancers, the details of this process are unclear. Here we review work showing that hTERT expression is in part regulated by atypical alternative splicing, perhaps due to its exceptionally low expression level. We propose that these differential regulatory mechanisms may be widely applicable to other genes and may provide new opportunities for the development of cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)430-438
Number of pages9
JournalTrends in Genetics
Volume30
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Telomerase
Alternative Splicing
Genes
Neoplasms
Genome
Messenger RNA
Proteins
Therapeutics

Keywords

  • Cancer therapy
  • Low-abundance transcript
  • Regulation
  • RNA splicing
  • Telomere

ASJC Scopus subject areas

  • Genetics

Cite this

Alternative splicing regulation of telomerase : A new paradigm? / Wong, Mandy S.; Wright, Woodring E.; Shay, Jerry W.

In: Trends in Genetics, Vol. 30, No. 10, 01.10.2014, p. 430-438.

Research output: Contribution to journalArticle

@article{21efad9ae525482991321fa423fadfdd,
title = "Alternative splicing regulation of telomerase: A new paradigm?",
abstract = "Alternative splicing affects approximately 95{\%} of eukaryotic genes, greatly expanding the coding capacity of complex genomes. Although our understanding of alternative splicing has increased rapidly, current knowledge of splicing regulation has largely been derived from studies of highly expressed mRNAs. Telomerase is a key example of a protein that is alternatively spliced, but it is expressed at very low levels and although it is known that misregulation of telomerase splicing is a hallmark of nearly all cancers, the details of this process are unclear. Here we review work showing that hTERT expression is in part regulated by atypical alternative splicing, perhaps due to its exceptionally low expression level. We propose that these differential regulatory mechanisms may be widely applicable to other genes and may provide new opportunities for the development of cancer therapeutics.",
keywords = "Cancer therapy, Low-abundance transcript, Regulation, RNA splicing, Telomere",
author = "Wong, {Mandy S.} and Wright, {Woodring E.} and Shay, {Jerry W.}",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.tig.2014.07.006",
language = "English (US)",
volume = "30",
pages = "430--438",
journal = "Trends in Genetics",
issn = "0168-9525",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Alternative splicing regulation of telomerase

T2 - A new paradigm?

AU - Wong, Mandy S.

AU - Wright, Woodring E.

AU - Shay, Jerry W.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Alternative splicing affects approximately 95% of eukaryotic genes, greatly expanding the coding capacity of complex genomes. Although our understanding of alternative splicing has increased rapidly, current knowledge of splicing regulation has largely been derived from studies of highly expressed mRNAs. Telomerase is a key example of a protein that is alternatively spliced, but it is expressed at very low levels and although it is known that misregulation of telomerase splicing is a hallmark of nearly all cancers, the details of this process are unclear. Here we review work showing that hTERT expression is in part regulated by atypical alternative splicing, perhaps due to its exceptionally low expression level. We propose that these differential regulatory mechanisms may be widely applicable to other genes and may provide new opportunities for the development of cancer therapeutics.

AB - Alternative splicing affects approximately 95% of eukaryotic genes, greatly expanding the coding capacity of complex genomes. Although our understanding of alternative splicing has increased rapidly, current knowledge of splicing regulation has largely been derived from studies of highly expressed mRNAs. Telomerase is a key example of a protein that is alternatively spliced, but it is expressed at very low levels and although it is known that misregulation of telomerase splicing is a hallmark of nearly all cancers, the details of this process are unclear. Here we review work showing that hTERT expression is in part regulated by atypical alternative splicing, perhaps due to its exceptionally low expression level. We propose that these differential regulatory mechanisms may be widely applicable to other genes and may provide new opportunities for the development of cancer therapeutics.

KW - Cancer therapy

KW - Low-abundance transcript

KW - Regulation

KW - RNA splicing

KW - Telomere

UR - http://www.scopus.com/inward/record.url?scp=84921933233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921933233&partnerID=8YFLogxK

U2 - 10.1016/j.tig.2014.07.006

DO - 10.1016/j.tig.2014.07.006

M3 - Article

VL - 30

SP - 430

EP - 438

JO - Trends in Genetics

JF - Trends in Genetics

SN - 0168-9525

IS - 10

ER -